EquityFlow
›
Companies
› Genesis Therapeutics
Genesis Therapeutics
Biotech
· Burlingame, US
AI-driven small-molecule drug discovery platform (GEMS)
Funding history
Date
Round
Amount
Aug 2023
Funding round
US AI drug-discovery company Genesis Therapeutics raised a $200m round co-led by Andreessen Horowitz, with Fidelity, BlackRock and NVentures.
$200M
Investors
Andreessen Horowitz
BlackRock
Fidelity Management and Research
NVentures
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →